OWEGO, NY – GI Cryo, Inc a start-up med tech company focused on developing and commercializing novel cryoablation technology platform to treat pancreatic cancer and other gastrointestinal related cancers, announced today that John M. Baust, PhD will deliver a corporate presentation at the Boston Oncology Investor Conference 2019 on Friday, March 15 at 9:35 AM ET. The event will take place at 28 State Street, Boston, MA. Visit www.gicryo.us to learn more about the FrostBite technology platform.
Information about the Boston Oncology Investor Conference 2019 can be found at www.oncologyinvestorconference.com. GI Cryo has partnered with CPSI Biotech to bring the innovative GastroCS and FrostBite EUS Cryocatheter cryoablation platform to commercialization.